BOTHELL, Wash., Oct. 29, 2007 (PRIME NEWSWIRE) -- Sonus Pharmaceuticals, Inc. (Nasdaq:SNUS) today announced that it will hold its quarterly conference call regarding third quarter financial results on Monday, November 12, 2007, at 1:30 p.m. PT/4:30 p.m. ET.
The third quarter conference call will be broadcast live and can be accessed on the Sonus web site at http://ir.sonuspharma.com/events.cfm. The call will be archived at the same link. A telephone replay of the call will be available from November 12, 3:30 p.m. Pacific Time, for one week at 800-405-2236 or 303-590-3000 for international calls; Conference ID: 11101278.
About Sonus Pharmaceuticals
Headquartered near Seattle, Washington, Sonus Pharmaceuticals, Inc. is focused on the development of cancer drugs that are designed to provide better efficacy, safety and tolerability, and ease of use. Sonus moved its second oncology product candidate, SN2310, into a Phase 1 clinical trial in September 2006. For additional information on Sonus, including past news releases, please visit www.sonuspharma.com.